Potential biomarkers to follow the progression and treatment response of Huntington’s disease

Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Disatnik, Marie-Hélène, Joshi, Amit U., Saw, Nay L., Shamloo, Mehrdad, Leavitt, Blair R., Qi, Xin, Mochly-Rosen, Daria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110026/
https://www.ncbi.nlm.nih.gov/pubmed/27821553
http://dx.doi.org/10.1084/jem.20160776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110026/
https://www.ncbi.nlm.nih.gov/pubmed/27821553
http://dx.doi.org/10.1084/jem.20160776

Ejemplares similares